270TiP - Mutanome engineered RNA immuno-therapy (MERIT) for patients with triple negative breast cancer (TNBC)
- Resource Type
- Abstract
- Authors
- Heesen, L.; Frenzel, K.; Bolte, S.; Bukur, V.; Diken, M.; Derhovanessian, E.; Kreiter, S.; Kuhn, A.; Kühlcke, K.; Löwer, M.; Lindman, H.; Pascolo, S.; Schmidt, M.; Schneeweiss, A.; Sjöblom, T.; Thielemans, K.; Zitvogel, L.; Türeci, Ö; Sahin, U.
- Source
- In Annals of Oncology October 2018 29 Supplement 8
- Subject
- Language
- ISSN
- 0923-7534